Baicalin, an emerging multi-therapeutic agent: Pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives

Xenobiotica

Volumn 40, Issue 5, 2010, Pages 357-367

  Srinivas, N R ^a  

^a Suramus Biopharm   (India)

Author keywords

Baicalin; Drug development; Drug drug interaction; Pharmacodynamics; Pharmacokinetics

Indexed keywords

AMPICILLIN; ARTEMISININ; ATORVASTATIN; BAICALEIN; BAICALIN; BOSENTAN; CHLOROGENIC ACID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOCHROME P450 2B6; CYTOCHROME P450 2E1; EFAVIRENZ; EZETIMIBE; IFOSFAMIDE; ISONIAZID; ISTRADEFYLLINE; KETAMINE; METFORMIN; METHADONE; MYCOPHENOLIC ACID; OXYMATRINE; PLANT EXTRACT; PROADIFEN; PROPOFOL; QUINIDINE; RALOXIFENE; ROSUVASTATIN; SALVINORIN A; SCUTELLARIAE RADIX EXTRACT; SILDENAFIL; UNCLASSIFIED DRUG; FLAVONOID;

ACUTE PANCREATITIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BACTERIAL MENINGITIS; BILIARY EXCRETION; BRAIN; CONJUGATE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENCY; ENZYME INHIBITION; EXPERIMENTAL RABBIT; EXPERIMENTAL RAT; FATTY LIVER; HUMAN; IN VITRO STUDY; LENS; METABOLIC DISORDER; MICROENVIRONMENT; NONHUMAN; PHARMACODYNAMICS; PROTEIN EXPRESSION; REVIEW; STREPTOZOCIN DIABETES; SUSTAINED DRUG RELEASE; THYMUS; ANIMAL; CHEMISTRY; DRUG DEVELOPMENT;

BACTERIA (MICROORGANISMS);

ANIMALS; DRUG DISCOVERY; FLAVONOIDS;

EID: 77950850484     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498251003663724     Document Type: Review

References (58)

1. Akao T, Kawabata K, Yanagisawa E, Ishihara K, Mizuhara Y, Wakui Y, Sakashita Y, Kobashi K. (2000). Baicalin, the predominant flavones glucuronide of Scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J Pharmacy Pharmacol 52:1563-1568
2. Akao T, Sakashita Y, Hanada M, Goto H, Shimada Y, Teresawa K. (2004). Enteric excretion of baicalein, a flavones of Scutellariae radix, via glucuronidation in rat: involvement of multidrug resistanceassociated protein 2. Pharmaceut Res 21:2120-2126
3. Akao T, Sato K, Hanada M. (2009). Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat. Biol Pharmaceut Bull 32:2079-2082
4. Asimus S, Ashton M. (2009). Artemisinin-a possible CYP2B6 probe substrate? Biopharmaceut Drug Disposit 30:265-275
5. Cabrera SE, Santos D, Valverde MP, Domínguez-Gil A, Gonzalez F, Luna G, Garcia MJ. (2009). Influence of the cytochrome P450 2B6 genotype on population pharmacokinetics of efavirenz in human immunodeficiency virus patients. Antimicrob Agent Chemother 53:2791-2798
6. Chang JH, Yoo P, Lee T, Klopf W, Takao D. (2009). The role of pH in the glucuronidation of raloxifene, mycophenolic acid and ezetimibe. Mol Pharmacol 6:1216-1227
7. Ernstgard L, Johanson G, Karlsson AS, Warholm M. (2007). Phenotyping of cytochrome P450 2E1 in vitro and in vivo. Curr Drug Metab 8:493-498
8. Fan L, Wang JC, Jiang F, Tan ZR, Chen Y, Li Q, Zhang W, Wang G, Lei HP, Hu DL, Wang D, Zhou HH. (2009). Induction of cytochrome P450 2B6 activity by the herbal medicine baicalin as measured by bupropion hydroxylation. Eur J Clin Pharmacol 65:403-409
9. Fan L, Zhang W, Guo D, Tan ZR, Xu P, Li Q, Liu YZ, Zhang L, He TY, Hu DL, Wang D, Zhou HH. (2008). The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1. Clin Pharmacol Therapeut 83:471-476
10. Gao R, Zheng Q, Gong T, Fu Y, Deng L, Zhang ZR. (2007). Gradient high-performance liquid chromatography for the simultaneous determination of chlorogenic acid and baicalin in plasma and its application in the study of pharmacokinetics in rats. J Pharmaceut Biomed Anal 43:335-340
11. Gao Z, Huang K, Yang X, Xu H. (1999). Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Biochimica Biophysics Acta 1472:643-650
12. Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S. (2004). Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Disposit 32:314-320 (Pubitemid 38263889)
13. Guo HX, Liu DH, Ma Y, Liu JF, Wang Y, Du ZY, Wang X, Shen JK, Peng HL. (2009). Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacologica Sinica 30:1505-1512.
14. Huang H, Zhang Y, Yang R, Tang X. (2008). Determination of baicalin in rat cerebrospinal fluid and blood using microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Tech Biomed Life Sci 874:77-83.
15. Ikemoto S, Sugimura K, Yoshida N, Yasumoto R, Wada S, Yamamoto K, Kishimoto T. (2000). Antitumor effects of Scutellariae radix and its components baicalein, baicalin, and wogonin on bladder cancer cell lines. Urology 55:951-955
16. Itoh T, itagaki S, Sumi Y, Hirano T, Takemoto I, Iseki K. (2005). Uptake of irinotecan metabolite SN-38 by the human intestinal cell line Caco-2. Cancer Chemother Pharmacol 55:420-424
17. Jang SI, Kim HJ, Hwang KM, Jekal SJ, Pae HO, Choi BM, Yun YG, Kwon TO, Chung HT, Kim YC. (2003). Hepatoprotective effect of baicalin, a major flavones from Scutellaria radix, on acetaminophen-induced liver injury in mice. Immunopharmacol Immunotoxicol 25:585-594
18. Jeong EJ, Liu Y, Lin H, Hu M. (2005). Species- and disposition model-dependent metabolism of raloxifene in gut and liver: role of UGT1A10. Drug Metab Disposit 33:785-794
19. Kim YH, Jeong DW, Paek IB, Ji HY, Kim YC, Sohn DH, Lee HS. (2006). Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and wogonin in rat plasma. J Chromatogr B Analyt Tech Biomed Life Sci 844:261-267
20. Kitamura K, Honda M, Yoshizaki H, Yamamoto S, Nakane H, Fukushima M, Ono K, Tokunga T. (1998). Baicalin, an inhibitor of HIV-1 production in vitro. Antiviral Res 37:131-140
21. Kotani A, Kojima S, Hakamata H, Kusu F. (2006). HPLC with electrochemical detection to examine the pharmacokinetics of baicalin and baicalein in rat plasma after oral administration of a Kampo medicine. Analyt Biochem 350:99-104.
22. Lai MY, Hsiu SL, Chen CC, Hou YC, Chao PD. (2003). Urinary pharmacokinetics of baicalein, wogonin, and their glycosides after oral administration of Scutellariae radix in humans. Biol Pharmaceut Bull 26:79-83.
23. Lai MY, Hsiu SL, Hou YC, Tsai SY, Chao PD. (2004). Significant decrease of cyclosporine bioavailability in rats caused by a decoction of the roots of Scutellaria baicalensis. Planta Medica 70:132-137
24. Lai MY, Hsiu SL, Tsai SY, Hou YC, Chao PD. (2003). Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats. J Pharmacy Pharmacol 55:205-209
25. Lau YY, Huang Y, Frassetto L, Benet LZ. (2007). Effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. Clin Pharmacol Therapeut 81:194-204.
26. Lee H, Kang R, Hahn Y, Yang Y, Kim SS, Cho SH, Chung SI, Yoon Y. (2009). Antiobesity effect of baicalin involves the modulations of proadipogenic and antiadipogenic regulators of the adipogenisis pathway. Phytother Res 23:1615-1623
27. Levesque E, Benoit-Biancamano MO, Delage R, Couture F, Guillemette C. (2008). Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. Pharmacogenomics 9:869-879
28. Liu L, Deng YX, Liang Y, Pang XY, Liu XD, Liu YW, Yang JS, Xie L, Wang GJ. (2010). Increased oral AUC of baicalin in streptozotocin-induced diabetic rats due to the increased activity of intestinal beta-glucuronidase. Planta Medica 76:70-75
29. Liu Z, Zhang X, Li J, Liu R, Shu L, Jin J. (2009). Effects of labrasol on the corneal drug delivery of baicalin. Drug Del 16:399-404.
30. Lu T, Song J, Huang F, Deng Y, Xie L, Wang G, Liu X. (2007). Comparative pharmacokinetics of baicalin after oral administration of pure baicalin, Radix scutellariae extract and Huang-Lian-Jie-Du-Tang to rats. J Ethnopharmacol 110:412-418
31. Noe J, Portmann R, Brun ME, Funk C. (2007). Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1:OATP2B1:and OATP1B3. Drug Metab Disposit 35:1308-1314
32. Oswald S, Konig J, Lutjohann D, Giessmann T, Kroemer HK, Rimmbach C, Rosskopf D, Fromm MF, Siegmund W. (2008). Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1. Pharmacogenet Gen 18:559-568
33. Qiu F, He ZG, Li HZ. (2003). HPLC analyses and pharmacokinetic studies of baicalin and oxymatrine in rabbits. Pharmazie 58:616-619
34. Ran X, Liang Q, Luo G, Liu Q, Pan Y, Wang B, Pang C. (2006). Simultaneous determination of geniposide, baicalin, cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatographytandem mass spectrometry. J Chromatogr B Analyt Tech Biomed Life Sci 842:22-27
35. Rao N, Dvorchik B, Sussman N, Wang H, Yamamoto K, Mori A, Uchimura T, Chaikin P. (2008). A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson's disease, and atorvastatin. J Clin Pharmacol 48:1092-1098
36. Shen YC, Chiou WF, Chou YC, Chen CF. (2003). Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465:171-181
37. Shieh DE, Liu LT, Lin CC. (2000). Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 20:2861-2865
38. Srinivas NR. (2009). Efflux transporter-mediated interactions with atorvastatin-interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin. J Clin Pharmacol 49:1492-1493
39. Taiming L, Xueha J. (2006). Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharmaceut Sci 95:1326-1333
40. Tang Y, Zhu H, Zhang Y, Huang C. (2006). Determination of human plasma protein binding of baicalin by ultrafiltration and highperformance liquid chromatography. Biomed Chromatogr 20:1116-1119
41. Tang YJ, Zhou FW, Luo ZQ, Li XZ, Yan HM, Wang MJ, Huang FR, and Yue SJ. (2009). Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis. Inflammation [DOI:10.1007/s10753-009-9172-9].
42. Teksin ZS, Lee IJ, Nemieboka NN, Othman AA, Upreti VV, Hassan HE, Syed SS, Prisinzano TE, Eddington ND. (2009). Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. Eur J Pharmaceut Biopharmaceut 72:471-477
43. Totah RA, Sheffels P, Roberts T, Whittington D, Thummel K, Kharasch ED. (2008). Role of CYP2B6 in stereoselective human methadone metabolism. Anesthesiology 108:363-374
44. Treiber A, Schneiter R, Hausler S, Stieger B. (2007). Bosentan is a substrate of human OATP1B1 and OATP1B3: inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Disposit 35:1400-1407
45. Tsai PL, Tsai TH. (2004). Pharmacokinetics of baicalin in rats and its interactions with cyclosporine A, quinidine and SKF-525A: a microdialysis study. Planta Medica 70:1069-1074
46. Turpeinen M, Raunio H, Pelkonen O. (2006). The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. Curr Drug Metab 7:705-714
47. Waisundara VY, Hsu A, Tan BK, Hunag D. (2009). Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabet Metab Res Rev 25:671-677
48. Xing J, Chen X, Sun Y, Luan Y, Zhong D. (2005). Interaction of baicalin and baicalein with antibiotics in the gastrointestinal tract. J Pharmacy Pharmacol 57:743-750
49. Xing J, Chen X, Zhong D. (2005). Absorption and enterohepatic circulation of baicalin in rats. Life Sci 78:140-146
50. Xiping Z, Guanghua F, Jinxian H, Weihog W, Rujun X, Wei Z, Jing Y, Qijun Y, Meijuan Y, Qing W, Lini F. (2009a). Baicalin protects thymus of rats with severe acute pancreatitis. Inflammation [DOI:10.1007/s10753-009-9169-4].
51. Xiping Z, Hua T, Jie Z, Li C, Yang C, Bei L, Qijun Y, Jing Y, Wengqin Y, Ninnin Z. (2009b). Influence of baicalin on TNF-alpha mRNA, caspase-3 and P-selectin expression in pancreatic tissue if rats with severe acute pancreatitis. Indian J Gastroenterology 28:131-135
52. Yi L, Jian-Ping G, Xu X, Lixin D. (2006). Simultaneous determination of baicalin, rhein and berberine in rat plasma by column-switching high-performance liquid chromatography. J Chromatogr B Analyt Tech Biomed Life Sci 838:50-55
53. Yue J, Peng R, Chen J, Liu Y, Dong G. (2009). Effects of rifampin on CYP2E1-dependent hepatotoxicity of isoniazid in rats. Pharmaceut Res 59:112-119
54. Zhang DM, Lu HY, Xie L, Liu XD. (2007). Effect of baicalin and berberine on transport of nimodipine on primary cultured, rat brain the microvascular endothelial cells. Acta Pharmacol Sinica 28:573-578
55. Zhang L, Lin G, Chang Q, Zuo Z. (2005). Role of intestinal first-pass metabolism of baicalin in its absorption process. Pharmaceut Res 22:1050-1058
56. Zhang X, Tain H, Wu C, Ye Q, Jiang X, Chen L, Cai Y, Xu R, Yuan W. (2009). Effect of baicalin on inflammatory mediatory levels and microcirculation disturbance in rats with severe acute pancreatitis. Pancreas 38:732-738
57. Zhiyan J, Zhengzhong B, Liange J, Shujie Z, Kai D, Hao C, Yongbin Y, Ping L. (2010). Ocular pharmacokinetic study on baicalin in lens of rabbits following intragastric administration. Graefes Archiv Clin Exp Opthalmol 248:59-63.
58. Zhou QM, Wang S, Zhang H, Lu YY, Wang XF, Motoo Y, Su SB. (2009). The combination of baicalin and baicalein enhances apoptosis via the ERK/p38 MAPK pathway in human breast cancer cells. Acta Pharmacol Sinica 30:1648-1658